Which of the following is true for patients treated with clomiphene –
**Core Concept**
Clomiphene is a selective estrogen receptor modulator (SERM) used in the treatment of infertility in women with ovulatory dysfunction. It works by competitively binding to estrogen receptors in the hypothalamus, leading to an increase in gonadotropin-releasing hormone (GnRH) secretion, which in turn stimulates the pituitary gland to release follicle-stimulating hormone (FSH) and luteinizing hormone (LH).
**Why the Correct Answer is Right**
Clomiphene increases the production of FSH and LH, stimulating the growth and maturation of follicles in the ovaries, ultimately leading to ovulation. This is achieved through its agonist activity on estrogen receptors in the hypothalamus, which mimics the effect of estrogen and triggers the release of GnRH. The increased levels of FSH and LH stimulate the ovaries to produce estrogen, which further enhances the feedback inhibition on GnRH release, creating a positive feedback loop that promotes ovulation.
**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because clomiphene does not directly stimulate the ovaries to produce estrogen; rather, it increases the production of FSH and LH, which in turn stimulate the ovaries to produce estrogen.
**Option B:** This option is incorrect because clomiphene is not an aromatase inhibitor; it works by binding to estrogen receptors, not by inhibiting the enzyme aromatase.
**Option C:** This option is incorrect because clomiphene is not a gonadotropin; it is a SERM that stimulates the release of gonadotropins (FSH and LH) from the pituitary gland.
**Option D:** This option is incorrect because clomiphene does not directly stimulate the growth and maturation of follicles in the ovaries; it increases the production of FSH and LH, which in turn stimulate the growth and maturation of follicles.
**Clinical Pearl / High-Yield Fact**
Clomiphene is often used in combination with ultrasound monitoring to predict ovulation and optimize treatment outcomes. It is essential to note that clomiphene can have a biphasic effect on estrogen levels, initially causing a decrease followed by an increase, which can lead to an increased risk of ovarian hyperstimulation syndrome (OHSS) in some patients.
**Correct Answer: C. Clomiphene is a selective estrogen receptor modulator (SERM) that increases the production of FSH and LH, stimulating the growth and maturation of follicles in the ovaries, ultimately leading to ovulation.**